✦ LIBER ✦

P101 A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer

✍ Scribed by M. De Tursi; C. Carella; E. Ricevuto; A. Gennari; C. Orlandini; A. Frassoldati; P.F. Conte; S. Iacobelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of epirubic

✍ M. Zilli; De Tursi; C. Carella; E. Ricevuto; P. Marchetti; A. Gennari; C. Orland 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

413 POSTER A multicenter phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A multicenter phase I–II study of doceta

✍ Tryfonidis, K.; Boukovinas, I.; Xenidis, N.; Christophyllakis, C.; Papakotoulas, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

A multinational phase II study of Navelb

✍ M Untch; S Kahlert; L Petruzelka; M Martin; V Guillem-Porta; M Gil; P Kellokumpu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 182 KB